Last updated: 2026-09-08 03:15:00. Prices reflect the latest closing data and will resume updating on the next trading day. Stock price data is sourced from Massive.
NRX Pharmaceuticals, Inc. (NRXP) operates in the PHARMACEUTICAL PREPARATIONS sector and is listed on NASDAQ. The stock is currently priced at $3.49, with a market capitalization of $151.10M and a P/E ratio of --. Over the past 52 weeks, its price has ranged from $1.62 to $5.06. This page covers its latest market performance, valuation, price trends and company information.
$151.10M | |
$3.43 | |
$262.40 | |
$1.10 | |
$3.43 | |
465.37K | |
985.26K | |
-- | |
$5.06 | |
$1.62 | |
-- | |
-- |
NRX Pharmaceuticals, Inc. (NRXP) last closed at $3.43 as of 2026-09-04 23:58:00, unchanged from the previous close of $3.43.
During the latest regular trading session, NRXP traded between $1.10 and $262.40, with a volume of 465.37K shares. The closing price was near the lower end and near the middle of its 52-week range.
Over the past seven days, NRX Pharmaceuticals, Inc. (NRXP) moved from $3.62 to $3.49, representing a decline of 3.70% ($0.13).
The stock traded between $3.38 and $3.68 during the period. The latest price is near the middle of the 7-day range, indicating moderate downward.
The average daily volume was 463.26 thousand shares, down versus the previous seven-day period, indicating lower trading activity.
Position in Range: 54.3%
NRXP is currently trading at $3.49, placing it 54.3% of the way from its 52-week low of $1.62 to its 52-week high of $5.06. This percentage reflects the stock's relative position within its 52-week trading range, not its valuation or future performance.
NRX Pharmaceuticals Inc is a clinical-stage, small-molecule pharmaceutical company that develops and plans to distribute novel therapeutics for the treatment of central nervous system disorders and life-threatening pulmonary diseases. The company is developing NRX-100/101, the first sequential drug regimen for bipolar depression in patients with acute suicidal ideation and behavior.
| Industry | PHARMACEUTICAL PREPARATIONS |
| Employees | 29 |
| Exchange | NASDAQ |
| Company Website |
Eligible investors can buy real shares of NRX Pharmaceuticals, Inc. (NRXP) through MEXC RealStocks. Follow these three steps to open a RealStocks account, transfer USDT, and place a US stock order.